Advancing Pulmonary Vascular Disease Care Through Research

Pulmonary vascular disease is a rapidly evolving field, with emerging therapies, new diagnostic approaches and ongoing research reshaping how patients with pulmonary hypertension are evaluated and treated.

By
October 22, 2026
3 min

Temple Health

1

The Temple Lung Center combines pulmonary vascular disease expertise with clinical research for patients with complex disease.
2

Active research includes studies of established WHO Group 1 pulmonary arterial hypertension and WHO Group 3 pulmonary hypertension associated with interstitial lung disease.
3

Clinical studies evaluate emerging treatment approaches and novel diagnostic methods, including artificial intelligence.
4

The multidisciplinary program collaborates with radiology, rheumatology, hematology, genetic testing, and cardiology specialists.
5

The Temple Lung Center reviews patients for trial eligibility or alternative treatment options, coordinates care, and communicates with referring physicians.

Advancing Pulmonary Vascular Disease Care Through Research

1

2

3

4

5

Original Source(s)

Advancing Pulmonary Vascular Disease Care Through Research

Related Content

MDA5-related juvenile dermatomyositis and interstitial lung disease: Transitioning from rapid progression to a quiescent state in three pediatric cases from South Africa, along with a literature review.

Evaluating Health-Related Quality of Life in Interstitial Lung Disease Patients With and Without Lung Transplantation Using the GR-Scale

RA Prescribing Patterns Shift Over 15 Years